| tgDCC-E1A |
Biologic therapy (BRM, immunotherapy)
|
Head & neck,
ovarian cancer
|
Yes
|
| sibrotuzumab |
Chemotherapy
|
Breast,
colorectal,
lung,
other cancer,
pancreatic
|
Yes
|
| sT4 |
AIDS drug
|
|
No
|
| rgp120/HIV-1 (IIIB) |
AIDS drug
|
|
No
|
| rgp120 CHO |
AIDS drug
|
|
No
|
| recMAGE-A3+AS15 |
Biologic therapy (BRM, immunotherapy)
|
Melanoma,
NSCLC
|
Yes
|
| radiotherapy |
Radiation
|
|
Yes
|
| rV-MART-1 |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rV-GP100 |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rF-gp100 |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rF-Tyrosine Vaccine |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rF-Mgp100 |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rF-MART-1 |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| rCD4 |
AIDS drug
|
|
No
|
| pivaloyloxymethylbutyrate |
Chemotherapy
|
Liver,
lung cancer
|
Yes
|
| p53 Tumor Suppressor Gene |
Biologic therapy (BRM, immunotherapy)
|
Head & neck,
liver,
ovarian cancer
|
Yes
|
| hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482 |
Chemotherapy
|
Kidney
|
Yes
|
| hR3 |
Biologic therapy (BRM, immunotherapy)
|
Head & neck cancer
|
Yes
|
| hIL13-PE38QQR (ligand targeted toxin) |
Chemotherapy
|
Kidney cancer
|
Yes
|
| gp100 Plasmid Vector in Gold Particles |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| gp100 Peptide Vaccine |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| gp100 DNA Vaccine |
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
| diazooxonorleucine |
Chemotherapy
|
Skin cancer
|
Yes
|
| dabrafenib |
Chemotherapy
|
Melanoma,
Lung,
Thyroid
|
Yes
|
| cAC10-vcMMAE(4) |
Chemotherapy
|
Hodgkin lymphoma
|
Yes
|
| anti-Tac(Fv)-PE38 (immunotoxin) |
Biologic therapy (BRM, immunotherapy)
|
Leukemia
|
Yes
|
| anti-CD72 |
Biologic therapy (BRM, immunotherapy)
|
Leukemia
|
Yes
|
| Zynyz |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| Zynlonta |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| Zykadia |
Chemotherapy
|
Lung
|
Yes
|
| Zydelig |
Chemotherapy
|
|
Yes
|
| Zosuquidar |
Ancillary Agent
|
|
No
|
| Zorubicin |
Chemotherapy
|
|
Yes
|
| Zoledronic acid |
Ancillary Agent
|
|
No
|
| Zoladex |
Hormones and hormonal mechanisms
|
Breast,
prostate cancer
|
Yes
|
| Zirabev |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| Zinostatin |
Chemotherapy
|
|
Yes
|
| Ziextenzo |
Ancillary Agent
|
|
No
|
| Zidovudine |
AIDS drug
|
|
No
|
| Zevalin |
Radiation
|
Lymphoma
|
Yes
|
| Zeniplatin |
Chemotherapy
|
|
Yes
|
| Zanubrutinib |
Chemotherapy
|
|
Yes
|
| Zanolimumab |
Biologic therapy (BRM, immunotherapy)
|
Cutaneous T-cell lymphoma,
mycosis fungoides
|
Yes
|
| Zamyl |
Biologic therapy (BRM, immunotherapy)
|
Leukemia
|
Yes
|
| Zalutumumab |
Chemotherapy
|
H&N,
NSCLC
|
Yes
|
| Zaltrap |
Chemotherapy
|
Colorectal
|
Yes
|
| Zalcitabine |
AIDS drug
|
|
No
|
| ZYC300 |
Biologic therapy (BRM, immunotherapy)
|
Breast,
colon,
kidney,
ovary,
prostate
|
Yes
|
| ZK Epothilone |
Chemotherapy
|
breast,
Prostate
|
Yes
|
| ZD6126 |
Chemotherapy
|
Breast,
cervical,
endometrial,
other cancer,
ovarian
|
Yes
|
| ZD0473 |
Chemotherapy
|
Lung,
ovarian Cancer
|
Yes
|
| Yoshi-864 |
Chemotherapy
|
|
Yes
|
| Yescarta |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| YMB-1003MAb |
Biologic therapy (BRM, immunotherapy)
|
Colorectal cancer
|
Yes
|
| YM598 |
Chemotherapy
|
Pancreatic caner
|
Yes
|
| Y-CEA-Cide |
Radiation
|
Pancreatic cancer
|
Yes
|
| Xyotax |
Chemotherapy
|
Breast,
colorectal,
lung,
ovarian cancer
|
Yes
|
| Xpovio |
Chemotherapy
|
|
Yes
|
| Xofigo |
Radiation
|
Metastatic prostate cancer
|
Yes
|
| Xermelo |
Ancillary Agent
|
|
No
|
| Xerecept |
Ancillary Agent
|
Brain cancer
|
Yes
|
| Xeloda |
Chemotherapy
|
|
Yes
|
| Xcytrin |
Ancillary Agent
|
Brain,
Lung cancer
|
No
|
| Xcellerate |
Biologic therapy (BRM, immunotherapy)
|
Kidney,
prostate cancer
|
Yes
|
| Xalkori |
Chemotherapy
|
Non Small Cell Lung Cancer (NSCLC)
|
Yes
|
| Xaliproden |
Ancillary Agent
|
|
No
|
| XL-888 |
Chemotherapy
|
Failed first course,
melanoma,
mets,
NSCLC,
or unresectable: breast
|
Yes
|
| XL-765 |
Chemotherapy
|
breast,
Malignant glioma,
NSCLC
|
Yes
|
| XL-281 |
Chemotherapy
|
colorectal,
melanoma,
NSC,
papillary thyroid
|
Yes
|
| XL-184 |
Chemotherapy
|
GBM,
NSCLC,
solid tumors,
Thyroid
|
Yes
|
| XL-147 |
Chemotherapy
|
Advanced Endometrium,
lymphoma,
Mets breast,
NSCLC,
ovarian
|
Yes
|
| XL-139 |
Chemotherapy
|
GE and esophageal adenocarcinoma,
inoperable stomach,
mets gastric,
multiiple myeloma,
SCLC
|
Yes
|
| XK469 |
Chemotherapy
|
advanced solid tumors,
Lymphoma
|
Yes
|
| XK-469 |
Chemotherapy
|
Other cancer
|
Yes
|
| XIAP antisense |
Chemotherapy
|
AML
|
Yes
|
| Wobenzym |
AIDS drug
|
|
No
|
| Warfarin Sodium |
Ancillary Agent
|
|
See Remarks
|
| WX-UK1 |
Chemotherapy
|
Gastric,
ovarian,
pancreatic cancer
|
Yes
|
| WT-1 peptide vaccine |
Biologic therapy (BRM, immunotherapy)
|
Pleura
|
See Remarks
|
| WR 6026 |
AIDS drug
|
|
No
|
| WR 2026 |
Ancillary Agent
|
|
No
|
| WF10 |
AIDS drug
|
Lymphoma
|
No
|
| Vyxeos |
Chemotherapy
|
|
Yes
|
| Vorinostat |
Chemotherapy
|
advanced solid tumors,
colorectal,
CTCL,
Leukemia,
other cancer
|
Yes
|
| Voriconazole |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Voraxase |
Ancillary Agent
|
|
No
|
| Vonjo |
Chemotherapy
|
Bone marrow
|
Yes
|
| Volasertib |
Chemotherapy
|
AML trials,
Ovarian trials,
Solid tumors trials
|
Yes
|
| Vitaxin |
Chemotherapy
|
Colorectal,
other cancer
|
Yes
|
| Vitamin E |
Ancillary Agent
|
|
No
|
| Vitamin D |
Ancillary Agent
|
|
No
|
| Vistogard |
Ancillary Agent
|
|
No
|
| Vismodegib |
Chemotherapy
|
Basal cell carcinoma, skin
|
Yes
|
| Virulizin |
Biologic therapy (BRM, immunotherapy)
|
Pancreatic cancer
|
Yes
|
| Vinzolidine Sulfate |
Chemotherapy
|
|
Yes
|
| Vinrosidine Sulfate |
Chemotherapy
|
|
Yes
|
| Vinorelbine |
Chemotherapy
|
Breast,
lung cancer
|
Yes
|
| Vinleurosine Sulfate |
Chemotherapy
|
|
Yes
|
| Vinglycinate Sulfate |
Chemotherapy
|
|
Yes
|
| Vinflunine |
Chemotherapy
|
Bladder,
breast,
lung,
other
|
Yes
|
An official website of the United States government
Home
